Donald G Hopkins, MD
Cardiovascular Disease (Cardiology) · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 48 years
- Baylor College of Medicine, 1978
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Adventist Health Mendocino Coast · Adventist Health Ukiah Valley · Novato Community Hospital · Sutter Lakeside Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hopkins’s office to ask if they take your plan before you enroll.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Mendocino CoastFort Bragg, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 5 of 5 · 80% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Adventist Health Ukiah ValleyUkiah, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.9 (5.8 to 10.5) · 253 cases, Jan 2024 – Dec 2024
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Sutter Lakeside HospitalLakeport, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Mendocino Coast
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 9 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 103 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 268 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 78 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -24.2 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.7 · 102 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 101 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.7 (5.2 to 11.1) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.3 to 14.6) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.8 to 17.4) · 526 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 48 cases | No different | Jan 2024 – Dec 2024 |
What patients said (119 patients answered, 22% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 86% |
| Doctors "always" communicated well | 89% |
| Staff "always" explained | 72% |
| Yes, staff "did" give patients this information | 94% |
| Yes, staff "did" give patients information about help after discharge | 94% |
| Doctors "always" explained things so they could understand | 85% |
| Doctors "always" listened carefully | 87% |
| Doctors "always" treated them with courtesy and respect | 96% |
| Patients who gave a rating of "9" or "10" (high) | 86% |
| Staff "always" explained new medications | 87% |
| Nurses "always" explained things so they could understand | 82% |
| Nurses "always" listened carefully | 84% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Adventist Health Ukiah Valley
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.9 (5.8 to 10.5) · 253 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 319 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.51 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 647 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,093 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.51) · 2,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.64 (2.23 to 7.05) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.79 to 4.11) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.96 (0 to 15.74) · 117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.32 (2.24 to 10.4) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 1,614 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.891 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.607 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.396 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 114 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.9 · 171 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 270 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (8 to 13.6) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.4 to 17.4) · 1,320 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 361 cases | No different | Jan 2024 – Dec 2024 |
What patients said (341 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sutter Lakeside Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 8.7 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 133 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 379 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 31 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.249 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -25.4 · 92 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -37.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 109 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.3) · 564 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 52 cases | No different | Jan 2024 – Dec 2024 |
What patients said (209 patients answered, 18% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 58% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$317,043
Medicare paid this office $317,043 for 1,634 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 919 | $128,506 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 314 | $50,651 | $155 |
| Short return visit (20+ min) | 298 | $21,581 | $67 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 957 | $16,774 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 992 | $13,136 | $12 |
See all 25 services
| Return visit (30+ min) | 919 | $128,506 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 314 | $50,651 | $155 |
| Short return visit (20+ min) | 298 | $21,581 | $67 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 957 | $16,774 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 992 | $13,136 | $12 |
| New patient visit (45+ min) | 85 | $11,576 | $136 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 17 | $11,247 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 167 | $8,383 | $50 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 162 | $8,090 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 125 | $7,288 | $21 |
| Long return visit (40+ min) | 51 | $7,223 | $129 |
| Programming of dual lead pacemaker system | 47 | $3,761 | $62 |
| New patient visit (60+ min) | 18 | $3,312 | $184 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 39 | $2,942 | $24 |
| External shock to heart to regulate heart beat | 18 | $1,698 | $85 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 25 | $1,376 | $55 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 62 | $1,252 | $20 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,011 | $92 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $950 | $86 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $861 | $66 |
| Heart rhythm recording of continous external ekg over 8-15 days | 47 | $471 | $10 |
| Ultrasound of heart, follow-up | 15 | $305 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 14 | $204 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $117 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $48 | $3 |
Who their Medicare patients are
1,634 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 17% · Women 46% · Also on Medicaid 10% · Health risk score 1.29. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 47% · Atrial fibrillation 41% · Heart failure 25% · Chronic kidney disease 23% · Diabetes 22% · Cancer 16% · COPD 15% · Depression 15% · Stroke 9% · Dementia 6%.
The office billed $1,539,822, Medicare allowed $446,182 and paid $317,043; for 6,245 services of 69 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,634 | 6,245 | 77 | 1.29 | $1,539,822 | $317,043 |
| 2023 | 1,517 | 5,016 | 77 | 1.25 | $1,478,211 | $316,978 |
| 2022 | 1,616 | 5,646 | 76 | 1.32 | $1,659,291 | $363,788 |
| 2021 | 1,680 | 5,069 | 76 | 1.40 | $1,560,640 | $358,957 |
| 2020 | 1,545 | 4,222 | 76 | 1.37 | $1,347,298 | $301,856 |
| 2019 | 1,645 | 5,530 | 75 | 1.38 | $1,587,561 | $338,353 |
| 2018 | 1,749 | 6,002 | 75 | 1.51 | $1,594,340 | $335,180 |
| 2017 | 1,737 | 5,214 | 75 | 1.49 | $1,362,084 | $301,820 |
| 2016 | 1,652 | 4,998 | 75 | 1.51 | $1,325,826 | $304,161 |
| 2015 | 1,548 | 4,490 | 76 | 1.51 | $927,394 | $261,557 |
| 2014 | 1,598 | 5,011 | 76 | 1.41 | $1,048,085 | $328,055 |
| 2013 | 1,305 | 4,332 | 76 | 1.40 | $875,659 | $268,002 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 30 services
| Return visit (30+ min) | 863 | $119,156 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 356 | $60,212 | $165 |
| Long return visit (40+ min) | 128 | $19,362 | $140 |
| New patient visit (45+ min) | 99 | $12,385 | $125 |
| Short return visit (20+ min) | 151 | $11,321 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 838 | $10,797 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 175 | $9,117 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 134 | $8,080 | $22 |
| New patient visit (60+ min) | 41 | $6,795 | $166 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 33 | $5,765 | $33 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 96 | $5,644 | $56 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 46 | $3,487 | $26 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 33 | $3,475 | $20 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 17 | $3,198 | $188 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 14 | $2,825 | $202 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,779 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,527 | $133 |
| Programming of dual lead pacemaker system | 28 | $2,167 | $59 |
| Critical care, first 30-74 minutes | 11 | $1,968 | $179 |
| External shock to heart to regulate heart beat | 18 | $1,849 | $92 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 83 | $1,806 | $21 |
| Telephone medical discussion with physician, 11-20 minutes | 28 | $1,607 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 26 | $1,536 | $59 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,354 | $90 |
| Heart rhythm recording of continous external ekg over 8-15 days | 43 | $497 | $11 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $319 | $10 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 14 | $280 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $227 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $226 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $50 | $3 |
2022: 33 services
| Return visit (30+ min) | 864 | $126,334 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 351 | $59,481 | $165 |
| Long return visit (40+ min) | 121 | $18,683 | $134 |
| New patient visit (45+ min) | 102 | $13,072 | $128 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $12,562 | $84 |
| Short return visit (20+ min) | 179 | $12,421 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 814 | $10,487 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 175 | $9,939 | $56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 201 | $9,843 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 148 | $8,229 | $22 |
| New patient visit (60+ min) | 47 | $8,202 | $175 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $8,061 | $152 |
| Injection, regadenoson, 0.1 mg | 29 | $4,923 | None |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 54 | $4,157 | $26 |
| Critical care, first 30-74 minutes | 20 | $3,680 | $184 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 34 | $3,534 | $21 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 33 | $3,237 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 65 | $3,221 | $49 |
| Programming of dual lead pacemaker system | 27 | $2,585 | $65 |
| External shock to heart to regulate heart beat | 28 | $2,550 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $2,428 | $59 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,320 | $178 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $2,287 | $191 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 72 | $1,614 | $22 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $1,553 | $86 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,462 | $91 |
| Telephone medical discussion with physician, 11-20 minutes | 29 | $1,454 | $48 |
| Heart rhythm recording of continous external ekg over 8-15 days | 39 | $514 | $13 |
| Ultrasound of heart, follow-up | 15 | $454 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 38 | $401 | $11 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 15 | $293 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $246 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $43 | $3 |
2021: 37 services
| Return visit (30+ min) | 669 | $90,391 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 364 | $65,759 | $175 |
| New patient visit (45+ min) | 162 | $20,497 | $127 |
| Long return visit (40+ min) | 88 | $15,081 | $151 |
| Short return visit (20+ min) | 183 | $13,729 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $13,527 | $161 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 233 | $13,003 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $11,167 | $86 |
| New patient visit (60+ min) | 48 | $9,157 | $191 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 706 | $8,954 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 205 | $8,695 | $23 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,586 | $470 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 144 | $6,512 | $25 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 33 | $5,983 | $181 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 44 | $4,041 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $4,041 | $60 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 44 | $3,746 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 61 | $3,674 | $31 |
| Critical care, first 30-74 minutes | 19 | $3,529 | $186 |
| Telephone medical discussion with physician, 11-20 minutes | 60 | $3,006 | $50 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 50 | $2,836 | $57 |
| Programming of dual lead pacemaker system | 28 | $2,816 | $70 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $2,119 | $88 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $2,047 | $171 |
| External shock to heart to regulate heart beat | 17 | $1,497 | $88 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 22 | $1,335 | $61 |
| Ultrasound of heart, follow-up | 14 | $1,278 | $85 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 57 | $1,263 | $22 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,155 | $89 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 77 | $851 | $11 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $820 | $19 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 30 | $597 | $20 |
| Ultrasound of heart, follow-up | 23 | $524 | $21 |
| Heart rhythm recording of continous external ekg over 8-15 days | 29 | $383 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 23 | $374 | $16 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 18 | $235 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $68 | $3 |
2020: 37 services
| Return visit (30+ min) | 657 | $72,375 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 347 | $61,030 | $171 |
| New patient visit (45+ min) | 143 | $18,063 | $126 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $13,359 | $165 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 215 | $12,813 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $12,319 | $86 |
| Telephone medical discussion with physician, 11-20 minutes | 178 | $11,756 | $62 |
| Short return visit (20+ min) | 167 | $9,652 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 665 | $9,598 | $13 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 18 | $9,018 | $475 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 39 | $7,791 | $200 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $5,571 | $61 |
| Injection, regadenoson, 0.1 mg | 22 | $4,106 | None |
| Telephone medical discussion with physician, 21-30 minutes | 46 | $4,098 | $89 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 70 | $3,725 | $53 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,178 | $265 |
| Long return visit (40+ min) | 18 | $2,083 | $116 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 91 | $1,944 | $21 |
| Transitional care management services for problem of at least moderate complexity | 11 | $1,805 | $164 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $1,716 | $132 |
| External ekg recording for more than 48 hours up to 21 days | 60 | $1,536 | $22 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,428 | $84 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 87 | $1,349 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 60 | $1,100 | $16 |
| Ultrasound of heart, follow-up | 13 | $1,080 | $77 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 17 | $1,052 | $62 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $1,047 | $81 |
| Ultrasound of heart, follow-up | 36 | $898 | $21 |
| Programming of dual lead pacemaker system | 16 | $891 | $52 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 83 | $887 | $10 |
| Telephone medical discussion with physician, 5-10 minutes | 22 | $680 | $31 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 27 | $551 | $18 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 12 | $518 | $17 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 12 | $429 | $14 |
| Short return visit | 11 | $349 | $32 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $223 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $39 | $3 |
2019: 38 services
| Return visit (30+ min) | 780 | $93,905 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 316 | $54,855 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 97 | $21,819 | $87 |
| New patient visit (45+ min) | 160 | $19,584 | $122 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 812 | $12,434 | $13 |
| Short return visit (20+ min) | 204 | $11,819 | $53 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 184 | $11,302 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $10,136 | $163 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 49 | $9,958 | $191 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 14 | $7,572 | $541 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $7,039 | $469 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 119 | $6,161 | $21 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $5,350 | $60 |
| Injection, regadenoson, 0.1 mg | 28 | $5,116 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 88 | $4,362 | $50 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 76 | $4,197 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 49 | $4,056 | $32 |
| New patient visit (60+ min) | 15 | $2,333 | $156 |
| Programming of dual lead pacemaker system | 37 | $2,306 | $49 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 15 | $2,276 | $152 |
| External ekg recording for more than 48 hours up to 21 days | 81 | $1,942 | $23 |
| Long return visit (40+ min) | 15 | $1,867 | $124 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 80 | $1,821 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 211 | $1,694 | $7 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 24 | $1,670 | $64 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 14 | $1,613 | $19 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,598 | $84 |
| New patient visit (30+ min) | 13 | $1,103 | $85 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 98 | $1,091 | $10 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,020 | $73 |
| External shock to heart to regulate heart beat | 11 | $934 | $78 |
| Programming of dual lead implantable defibrillator system | 12 | $869 | $72 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 14 | $776 | $9 |
| Evaluation of implantable heart and blood vessel monitoring system | 17 | $600 | $32 |
| Blood test, clotting time | 32 | $492 | $4 |
| Ultrasound of heart, follow-up | 17 | $458 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $294 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $54 | $3 |
2018: 40 services
| Return visit (30+ min) | 638 | $77,897 | $80 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 329 | $58,460 | $172 |
| Short return visit (20+ min) | 529 | $33,288 | $50 |
| New patient visit (45+ min) | 176 | $20,340 | $116 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 794 | $12,224 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 96 | $10,780 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 162 | $8,849 | $53 |
| Injection, regadenoson, 0.1 mg | 47 | $8,243 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 41 | $7,788 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $6,848 | $81 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $6,617 | $473 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 99 | $4,807 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 95 | $4,722 | $49 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 44 | $4,521 | $41 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $4,334 | $197 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,838 | $160 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 363 | $3,572 | $7 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,491 | $291 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,033 | $253 |
| Ultrasound of heart with probe in esophagus, with report | 33 | $2,984 | $90 |
| Long return visit (40+ min) | 25 | $2,816 | $108 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 57 | $2,779 | $22 |
| Transitional care management services for problem of high complexity | 14 | $2,735 | $195 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 29 | $2,227 | $77 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 95 | $2,156 | $22 |
| External ekg recording for more than 48 hours up to 21 days | 92 | $2,151 | $22 |
| External shock to heart to regulate heart beat | 21 | $2,100 | $91 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 15 | $2,086 | $139 |
| Programming of dual lead pacemaker system | 32 | $2,007 | $44 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,678 | $105 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 125 | $1,326 | $10 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,222 | $76 |
| Hospital discharge day management, more than 30 minutes | 11 | $955 | $87 |
| Injection for imaging of aorta above heart valve with review by radiologist | 22 | $928 | $42 |
| Short return visit | 17 | $687 | $36 |
| Blood test, clotting time | 25 | $570 | $5 |
| Ultrasound of heart blood flow, valves and chambers | 32 | $487 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $454 | $23 |
| Evaluation of implantable heart and blood vessel monitoring system | 11 | $362 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 32 | $85 | $3 |
2017: 39 services
| Return visit (30+ min) | 628 | $70,184 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 247 | $47,099 | $185 |
| Short return visit (20+ min) | 503 | $31,209 | $50 |
| New patient visit (45+ min) | 177 | $21,252 | $120 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 65 | $13,796 | $212 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 792 | $11,450 | $13 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $10,865 | $435 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 78 | $8,680 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 148 | $7,811 | $52 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $4,794 | $218 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 42 | $3,973 | $48 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 98 | $3,687 | $20 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $3,652 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 408 | $3,342 | $7 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 18 | $2,918 | $146 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 14 | $2,875 | $205 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 56 | $2,578 | $23 |
| Programming of dual lead pacemaker system | 42 | $2,453 | $43 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 30 | $2,390 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,221 | $111 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 99 | $2,173 | $21 |
| External ekg recording for more than 48 hours up to 21 days | 99 | $2,168 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 37 | $2,161 | $58 |
| Programming of dual lead implantable defibrillator system | 18 | $2,054 | $62 |
| Injection, regadenoson, 0.1 mg | 12 | $1,993 | None |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $1,960 | $75 |
| Long return visit (40+ min) | 15 | $1,790 | $119 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,706 | $90 |
| Programming of multiple lead implantable defibrillator system | 13 | $1,519 | $69 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 101 | $1,081 | $10 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,058 | $81 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | 11 | $742 | $62 |
| New patient visit (30+ min) | 11 | $676 | $61 |
| Short return visit | 17 | $618 | $34 |
| Injection for imaging of aorta above heart valve with review by radiologist | 13 | $548 | $42 |
| Blood test, clotting time | 19 | $354 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 28 | $342 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 18 | $272 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $50 | $3 |
2016: 35 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 281 | $53,582 | $186 |
| Short return visit (20+ min) | 664 | $53,122 | $52 |
| Return visit (30+ min) | 329 | $31,920 | $82 |
| New patient visit (45+ min) | 171 | $21,086 | $123 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 68 | $14,150 | $208 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 274 | $13,029 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 730 | $10,197 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 84 | $10,153 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $8,510 | $84 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $7,723 | $454 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $7,584 | $155 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 32 | $7,001 | $219 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 11 | $5,727 | $521 |
| New patient visit (30+ min) | 87 | $5,466 | $63 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $3,944 | $282 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,948 | $109 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 303 | $2,847 | $7 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 35 | $2,775 | $77 |
| Programming of dual lead pacemaker system | 44 | $2,733 | $41 |
| External ekg recording for more than 48 hours up to 21 days | 119 | $2,612 | $21 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 118 | $2,574 | $21 |
| Programming of dual lead implantable defibrillator system | 26 | $2,393 | $60 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 26 | $2,062 | $46 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 52 | $2,056 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 30 | $1,869 | $60 |
| Short return visit | 44 | $1,757 | $33 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 31 | $1,661 | $26 |
| Programming of multiple lead implantable defibrillator system | 14 | $1,628 | $71 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,292 | $99 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,136 | $87 |
| Injection for imaging of aorta above heart valve with review by radiologist | 20 | $841 | $42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 41 | $420 | $10 |
| Blood test, clotting time | 18 | $404 | $5 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $151 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $24 | $2 |
2015: 37 services
| Return visit (30+ min) | 606 | $61,145 | $77 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 150 | $28,062 | $182 |
| Short return visit (20+ min) | 385 | $24,955 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 99 | $16,302 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $11,331 | $162 |
| Long return visit (40+ min) | 80 | $9,427 | $106 |
| New patient visit (45+ min) | 79 | $8,929 | $113 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 161 | $8,579 | $51 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 39 | $8,419 | $216 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,325 | $487 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $6,003 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 396 | $5,584 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 376 | $4,070 | $7 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 15 | $3,961 | $248 |
| New patient visit (60+ min) | 23 | $3,496 | $152 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $3,362 | $306 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 36 | $3,109 | $49 |
| Programming of dual lead pacemaker system | 48 | $2,870 | $42 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 78 | $2,805 | $20 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,390 | $100 |
| New patient visit (30+ min) | 26 | $2,226 | $86 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 26 | $2,098 | $15 |
| Programming of dual lead implantable defibrillator system | 19 | $1,951 | $59 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 43 | $1,829 | $23 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $1,646 | $150 |
| Programming of multiple lead implantable defibrillator system | 12 | $1,301 | $72 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 16 | $1,254 | $78 |
| External ekg recording for more than 48 hours up to 21 days | 38 | $807 | $21 |
| Injection for imaging of aorta above heart valve with review by radiologist | 19 | $799 | $42 |
| Blood test, clotting time | 24 | $749 | $5 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 36 | $728 | $20 |
| Electrocardiogram (ecg) 2-day continuous | 26 | $483 | $19 |
| Short return visit | 13 | $471 | $36 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 21 | $441 | $21 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 22 | $400 | $7 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $318 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $70 | $3 |
2014: 37 services
| Return visit (30+ min) | 740 | $88,554 | $80 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 212 | $42,234 | $188 |
| New patient visit (45+ min) | 122 | $15,160 | $124 |
| Long return visit (40+ min) | 112 | $14,352 | $110 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $13,675 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 104 | $13,385 | $57 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 58 | $11,993 | $207 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $10,797 | $450 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $9,448 | $84 |
| Short return visit (20+ min) | 155 | $9,156 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 576 | $8,328 | $13 |
| New patient visit (60+ min) | 52 | $8,181 | $157 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 15 | $7,801 | $520 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 32 | $7,352 | $230 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | $5,111 | $52 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $4,247 | $303 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 34 | $4,113 | $51 |
| Programming of dual lead pacemaker system | 56 | $3,688 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 320 | $3,473 | $7 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 34 | $3,371 | $15 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 14 | $2,966 | $212 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 65 | $2,767 | $21 |
| Ultrasound of heart with probe in esophagus, with report | 28 | $2,397 | $86 |
| Programming of dual lead implantable defibrillator system | 18 | $1,724 | $62 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 22 | $1,623 | $71 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 31 | $1,407 | $27 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,388 | $87 |
| Blood test, clotting time | 39 | $1,262 | $5 |
| External shock to heart to regulate heart beat | 11 | $1,096 | $91 |
| Electrocardiogram (ecg) 2-day continuous | 31 | $647 | $20 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 26 | $558 | $20 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 16 | $553 | $21 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 25 | $532 | $7 |
| Injection for imaging of aorta above heart valve with review by radiologist | 13 | $515 | $40 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 18 | $426 | $21 |
| Ultrasound of heart blood flow, valves and chambers | 23 | $347 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $64 | $3 |
2013: 40 services
| Return visit (30+ min) | 615 | $68,081 | $79 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 161 | $24,794 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 109 | $15,612 | $56 |
| Short return visit (20+ min) | 224 | $13,892 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $13,827 | $157 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 55 | $10,315 | $188 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 17 | $9,229 | $513 |
| New patient visit (45+ min) | 74 | $8,966 | $121 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $8,915 | $446 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $8,779 | $81 |
| Long return visit (40+ min) | 69 | $8,292 | $109 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 459 | $6,998 | $14 |
| New patient visit (60+ min) | 32 | $5,086 | $159 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 43 | $4,718 | $43 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 19 | $4,622 | $243 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $4,349 | $49 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 42 | $3,939 | $15 |
| Hospital discharge day management, more than 30 minutes | 38 | $3,236 | $83 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $3,046 | $277 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,046 | $254 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 68 | $2,960 | $19 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 34 | $2,304 | $68 |
| Programming of dual lead pacemaker system | 39 | $2,301 | $42 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $2,175 | $181 |
| Ultrasound of heart with probe in esophagus, with report | 24 | $1,982 | $83 |
| Programming of dual lead implantable defibrillator system | 18 | $1,839 | $61 |
| Blood test, clotting time | 43 | $1,443 | $5 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 141 | $1,279 | $7 |
| External shock to heart to regulate heart beat | 12 | $1,162 | $97 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 26 | $925 | $20 |
| Injection for imaging of aorta above heart valve with review by radiologist | 23 | $880 | $38 |
| Programming of single lead pacemaker system | 11 | $630 | $39 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 23 | $495 | $6 |
| Short return visit | 13 | $470 | $36 |
| Electrocardiogram (ecg) 2-day continuous | 18 | $396 | $21 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 18 | $380 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 25 | $366 | $15 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 13 | $256 | $20 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 11 | $86 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $73 | $3 |
Medicaid work
$16,198 in 2024
Medicaid paid $16,198 for 292 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 133 | $7,267 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 62 | $5,298 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 83 | $2,342 |
| Long return visit (40+ min) | 14 | $1,290 |
| 2024 | 292 | 4 | 22 | $16,198 |
| 2023 | 485 | 4 | 25 | $26,468 |
| 2022 | 522 | 3 | 26 | $27,795 |
| 2021 | 679 | 3 | 28 | $41,913 |
| 2020 | 270 | 3 | 24 | $18,891 |
| 2019 | 157 | 2 | 44 | $7,586 |
| 2018 | 116 | 2 | 36 | $4,175 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 243 | $12,071 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 86 | $8,477 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 140 | $4,465 |
| Long return visit (40+ min) | 16 | $1,455 |
2022
| Return visit (30+ min) | 200 | $9,940 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 123 | $9,768 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 199 | $8,087 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 236 | $21,904 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 256 | $10,276 |
| Return visit (30+ min) | 187 | $9,733 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 172 | $15,033 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 63 | $2,331 |
| Return visit (30+ min) | 35 | $1,526 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 64 | $6,751 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 93 | $835 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 29 | $3,200 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 87 | $975 |
Drugs they prescribed that Part D paid
$2,302,249
Pharmacies billed $2,302,249 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 10,364) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
8,484 generic and 1,880 brand-name prescriptions · $2,302,249 in drug cost · 56 antibiotic prescriptions to 36 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 725 | $979,620 | $1,351 |
| Entresto | 362 | $428,343 | $1,183 |
| Repatha Sureclick | 247 | $239,289 | $969 |
| Jardiance | 155 | $180,444 | $1,164 |
| Xarelto | 92 | $119,697 | $1,301 |
See all 73 drugs
| Eliquis | 725 | $979,620 | $1,351 |
| Entresto | 362 | $428,343 | $1,183 |
| Repatha Sureclick | 247 | $239,289 | $969 |
| Jardiance | 155 | $180,444 | $1,164 |
| Xarelto | 92 | $119,697 | $1,301 |
| Praluent | 77 | $66,501 | $864 |
| Farxiga | 63 | $61,898 | $983 |
| Multaq | 29 | $40,590 | $1,400 |
| Atorvastatin | 1,352 | $18,194 | $13 |
| Metoprolol | 868 | $15,482 | $18 |
| Losartan | 791 | $11,922 | $15 |
| Rosuvastatin | 733 | $11,263 | $15 |
| Ezetimibe | 361 | $10,429 | $29 |
| Diltiazem 24hr Er (Cd) | 177 | $6,910 | $39 |
| Dofetilide | 36 | $6,766 | $188 |
| Dabigatran Etexilate | 21 | $5,374 | $256 |
| Carvedilol | 339 | $4,259 | $13 |
| Nebivolol | 63 | $4,174 | $66 |
| Sildenafil Citrate | 16 | $3,922 | $245 |
| Clopidogrel | 263 | $3,712 | $14 |
| Propafenone Hcl Er | 16 | $3,647 | $228 |
| Ranolazine Er | 39 | $3,383 | $87 |
| Amlodipine Besylate | 434 | $3,261 | $8 |
| Spironolactone | 299 | $2,787 | $9 |
| Eplerenone | 37 | $2,476 | $67 |
| Colesevelam | 12 | $2,372 | $198 |
| Diltiazem 24hr Er | 38 | $2,328 | $61 |
| Furosemide | 268 | $2,175 | $8 |
| Flecainide Acetate | 52 | $2,114 | $41 |
| Telmisartan | 25 | $2,107 | $84 |
| Pravastatin | 91 | $2,069 | $23 |
| Valsartan | 48 | $2,014 | $42 |
| Digoxin | 80 | $1,929 | $24 |
| Lisinopril | 210 | $1,794 | $9 |
| Hydrochlorothiazide | 259 | $1,697 | $7 |
| Benazepril | 102 | $1,665 | $16 |
| Warfarin | 107 | $1,600 | $15 |
| Bumetanide | 44 | $1,547 | $35 |
| Metoprolol | 170 | $1,462 | $9 |
| Amiodarone | 53 | $1,305 | $25 |
| Prasugrel | 14 | $1,305 | $93 |
| Bisoprolol | 54 | $1,183 | $22 |
| Nitroglycerin | 80 | $1,181 | $15 |
| Isosorbide Mononitrate Er | 62 | $906 | $15 |
| Olmesartan Medoxomil | 41 | $878 | $21 |
| Cartia Xt | 12 | $831 | $69 |
| Pantoprazole | 45 | $802 | $18 |
| Potassium Chloride | 54 | $787 | $15 |
| Verapamil Er | 33 | $765 | $23 |
| Fenofibrate | 12 | $735 | $61 |
| Irbesartan | 55 | $735 | $13 |
| Atenolol | 61 | $725 | $12 |
| Labetalol | 11 | $693 | $63 |
| Spironolactone-Hctz | 22 | $670 | $30 |
| Sotalol | 33 | $613 | $19 |
| Torsemide | 35 | $570 | $16 |
| Simvastatin | 45 | $472 | $10 |
| Nitroglycerin Patch | 17 | $440 | $26 |
| Propranolol | 24 | $350 | $15 |
| Omeprazole | 17 | $326 | $19 |
| Losartan-Hydrochlorothiazide | 35 | $303 | $9 |
| Clonidine | 27 | $300 | $11 |
| Levothyroxine | 25 | $285 | $11 |
| Diltiazem 24hr Er (Xr) | 11 | $282 | $26 |
| Benazepril-Hydrochlorothiazide | 15 | $264 | $18 |
| Hydralazine | 14 | $259 | $18 |
| Triamterene-Hydrochlorothiazid | 32 | $249 | $8 |
| Amoxicillin | 47 | $248 | $5 |
| Ramipril | 14 | $196 | $14 |
| Chlorthalidone | 14 | $190 | $14 |
| Lisinopril-Hydrochlorothiazide | 21 | $166 | $8 |
| Irbesartan-Hydrochlorothiazide | 11 | $164 | $15 |
| Diltiazem | 11 | $156 | $14 |
Year by year
| 2024 | 10,364 | 1,289 | 0% (0) | 18% | $2,302,249 |
| 2023 | 9,682 | 1,227 | 0% (0) | 17% | $2,053,428 |
| 2022 | 9,434 | 1,209 | None | 17% | $1,723,329 |
| 2021 | 8,703 | 1,150 | 0% (0) | 16% | $1,293,497 |
| 2020 | 9,083 | 1,059 | 0% (0) | 15% | $1,227,038 |
| 2019 | 8,687 | 988 | None | 14% | $1,063,414 |
| 2018 | 8,698 | 927 | 0% (0) | 14% | $842,293 |
| 2017 | 7,531 | 828 | None | 17% | $688,222 |
| 2016 | 5,822 | 773 | None | 21% | $505,778 |
| 2015 | 3,804 | 747 | None | None | $332,722 |
| 2014 | 3,408 | 652 | None | 27% | $277,805 |
| 2013 | 3,406 | 571 | None | 26% | $206,587 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 73 drugs
| Eliquis | 677 | $895,447 | $1,323 |
| Entresto | 270 | $335,315 | $1,242 |
| Repatha Sureclick | 193 | $194,132 | $1,006 |
| Xarelto | 105 | $132,990 | $1,267 |
| Praluent | 97 | $91,856 | $947 |
| Jardiance | 73 | $71,921 | $985 |
| Farxiga | 33 | $38,365 | $1,163 |
| Atorvastatin | 1,306 | $21,046 | $16 |
| Metoprolol | 819 | $18,556 | $23 |
| Multaq | 13 | $17,966 | $1,382 |
| Rosuvastatin | 595 | $16,953 | $28 |
| Losartan | 716 | $16,543 | $23 |
| Ezetimibe | 273 | $15,043 | $55 |
| Brilinta | 18 | $13,559 | $753 |
| Diltiazem 24hr Er (Cd) | 203 | $13,018 | $64 |
| Dofetilide | 34 | $11,831 | $348 |
| Livalo | 16 | $11,243 | $703 |
| Repatha Pushtronex | 14 | $9,234 | $660 |
| Carvedilol Er | 14 | $7,922 | $566 |
| Nebivolol | 33 | $7,393 | $224 |
| Pradaxa | 12 | $5,636 | $470 |
| Clopidogrel | 292 | $5,517 | $19 |
| Carvedilol | 313 | $4,672 | $15 |
| Warfarin | 157 | $4,063 | $26 |
| Amlodipine Besylate | 442 | $3,973 | $9 |
| Bisoprolol | 55 | $3,858 | $70 |
| Flecainide Acetate | 59 | $3,671 | $62 |
| Digoxin | 95 | $3,254 | $34 |
| Spironolactone | 268 | $3,036 | $11 |
| Lisinopril | 257 | $2,940 | $11 |
| Propafenone Hcl Er | 14 | $2,881 | $206 |
| Vascepa | 11 | $2,374 | $216 |
| Ranolazine Er | 17 | $2,309 | $136 |
| Pravastatin | 79 | $2,275 | $29 |
| Diltiazem 24hr Er | 29 | $2,266 | $78 |
| Irbesartan | 57 | $2,206 | $39 |
| Metoprolol | 195 | $2,137 | $11 |
| Benazepril | 117 | $2,077 | $18 |
| Bumetanide | 41 | $2,070 | $50 |
| Furosemide | 268 | $2,060 | $8 |
| Valsartan | 36 | $1,996 | $55 |
| Eplerenone | 16 | $1,899 | $119 |
| Prasugrel | 29 | $1,702 | $59 |
| Hydrochlorothiazide | 255 | $1,575 | $6 |
| Potassium Chloride | 57 | $1,556 | $27 |
| Isosorbide Mononitrate Er | 47 | $1,312 | $28 |
| Nitroglycerin | 65 | $1,297 | $20 |
| Telmisartan | 24 | $1,155 | $48 |
| Olmesartan Medoxomil | 25 | $1,096 | $44 |
| Torsemide | 34 | $1,000 | $29 |
| Spironolactone-Hctz | 20 | $923 | $46 |
| Atenolol | 66 | $866 | $13 |
| Pantoprazole | 43 | $834 | $19 |
| Sotalol | 25 | $819 | $33 |
| Benazepril-Hydrochlorothiazide | 16 | $794 | $50 |
| Nitroglycerin Patch | 23 | $790 | $34 |
| Hydralazine | 22 | $774 | $35 |
| Chlorthalidone | 22 | $724 | $33 |
| Verapamil Er | 21 | $693 | $33 |
| Doxazosin Mesylate | 19 | $663 | $35 |
| Amiodarone | 29 | $663 | $23 |
| Losartan-Hydrochlorothiazide | 37 | $644 | $17 |
| Labetalol | 13 | $573 | $44 |
| Valsartan-Hydrochlorothiazide | 18 | $541 | $30 |
| Simvastatin | 62 | $502 | $8 |
| Triamterene-Hydrochlorothiazid | 28 | $487 | $17 |
| Clonidine | 23 | $442 | $19 |
| Omeprazole | 19 | $339 | $18 |
| Ramipril | 16 | $337 | $21 |
| Levothyroxine | 16 | $330 | $21 |
| Amoxicillin | 37 | $132 | $4 |
| Diltiazem | 12 | $84 | $7 |
| Lisinopril-Hydrochlorothiazide | 11 | $68 | $6 |
2022: 73 drugs
| Eliquis | 667 | $780,296 | $1,170 |
| Entresto | 168 | $198,352 | $1,181 |
| Repatha Sureclick | 205 | $174,855 | $853 |
| Xarelto | 124 | $136,732 | $1,103 |
| Praluent | 88 | $68,992 | $784 |
| Brilinta | 43 | $26,705 | $621 |
| Pradaxa | 31 | $23,780 | $767 |
| Rosuvastatin | 564 | $23,726 | $42 |
| Jardiance | 30 | $19,463 | $649 |
| Atorvastatin | 1,274 | $18,514 | $15 |
| Ezetimibe | 258 | $17,947 | $70 |
| Metoprolol | 735 | $17,189 | $23 |
| Livalo | 23 | $14,653 | $637 |
| Diltiazem 24hr Er (Cd) | 249 | $12,859 | $52 |
| Repatha Pushtronex | 19 | $11,222 | $591 |
| Losartan | 652 | $10,945 | $17 |
| Carvedilol Er | 14 | $8,395 | $600 |
| Dofetilide | 26 | $7,709 | $296 |
| Prasugrel | 19 | $6,793 | $358 |
| Clopidogrel | 286 | $6,197 | $22 |
| Sildenafil Citrate | 15 | $5,750 | $383 |
| Carvedilol | 351 | $5,482 | $16 |
| Warfarin | 175 | $4,678 | $27 |
| Nebivolol | 24 | $4,663 | $194 |
| Bisoprolol | 72 | $4,550 | $63 |
| Flecainide Acetate | 54 | $3,990 | $74 |
| Amlodipine Besylate | 412 | $3,743 | $9 |
| Propafenone Hcl Er | 11 | $3,433 | $312 |
| Spironolactone | 259 | $3,191 | $12 |
| Eplerenone | 14 | $3,050 | $218 |
| Digoxin | 63 | $2,908 | $46 |
| Metoprolol | 248 | $2,741 | $11 |
| Valsartan | 45 | $2,484 | $55 |
| Omega-3 Acid Ethyl Esters | 12 | $2,404 | $200 |
| Vascepa | 12 | $2,375 | $198 |
| Pravastatin | 99 | $2,305 | $23 |
| Sotalol | 57 | $2,172 | $38 |
| Furosemide | 281 | $1,981 | $7 |
| Lisinopril | 215 | $1,945 | $9 |
| Nitroglycerin | 75 | $1,933 | $26 |
| Potassium Chloride | 69 | $1,912 | $28 |
| Hydrochlorothiazide | 275 | $1,868 | $7 |
| Diltiazem 24hr Er | 31 | $1,847 | $60 |
| Bumetanide | 21 | $1,673 | $80 |
| Benazepril | 99 | $1,640 | $17 |
| Telmisartan | 29 | $1,638 | $56 |
| Isosorbide Mononitrate Er | 56 | $1,563 | $28 |
| Irbesartan | 64 | $1,519 | $24 |
| Hydralazine | 35 | $1,314 | $38 |
| Nitroglycerin Patch | 25 | $1,203 | $48 |
| Torsemide | 31 | $1,193 | $38 |
| Losartan-Hydrochlorothiazide | 43 | $1,064 | $25 |
| Olmesartan Medoxomil | 23 | $961 | $42 |
| Valsartan-Hydrochlorothiazide | 16 | $932 | $58 |
| Amiodarone | 35 | $813 | $23 |
| Dilt-Xr | 11 | $790 | $72 |
| Simvastatin | 61 | $728 | $12 |
| Spironolactone-Hctz | 15 | $714 | $48 |
| Pantoprazole | 40 | $686 | $17 |
| Doxazosin Mesylate | 23 | $653 | $28 |
| Labetalol | 13 | $643 | $49 |
| Chlorthalidone | 19 | $551 | $29 |
| Atenolol | 36 | $510 | $14 |
| Benazepril-Hydrochlorothiazide | 12 | $445 | $37 |
| Omeprazole | 17 | $387 | $23 |
| Triamterene-Hydrochlorothiazid | 24 | $370 | $15 |
| Propranolol | 11 | $355 | $32 |
| Clonidine | 21 | $315 | $15 |
| Verapamil Er | 11 | $270 | $25 |
| Ramipril | 13 | $236 | $18 |
| Levothyroxine | 11 | $182 | $17 |
| Lisinopril-Hydrochlorothiazide | 17 | $143 | $8 |
| Amoxicillin | 28 | $87 | $3 |
2021: 68 drugs
| Eliquis | 579 | $603,434 | $1,042 |
| Entresto | 128 | $133,162 | $1,040 |
| Repatha Sureclick | 175 | $107,629 | $615 |
| Xarelto | 88 | $95,775 | $1,088 |
| Praluent | 84 | $49,201 | $586 |
| Brilinta | 55 | $29,820 | $542 |
| Atorvastatin | 1,195 | $20,547 | $17 |
| Pradaxa | 26 | $17,992 | $692 |
| Bystolic | 24 | $16,637 | $693 |
| Metoprolol | 638 | $16,426 | $26 |
| Rosuvastatin | 487 | $15,427 | $32 |
| Ezetimibe | 207 | $14,602 | $71 |
| Losartan | 635 | $12,109 | $19 |
| Diltiazem 24hr Er (Cd) | 218 | $12,005 | $55 |
| Carvedilol Er | 16 | $7,938 | $496 |
| Dofetilide | 15 | $5,778 | $385 |
| Valsartan | 62 | $5,598 | $90 |
| Warfarin | 197 | $5,304 | $27 |
| Carvedilol | 336 | $5,215 | $16 |
| Bisoprolol | 71 | $4,820 | $68 |
| Prasugrel | 21 | $4,170 | $199 |
| Amlodipine Besylate | 436 | $3,779 | $9 |
| Clopidogrel | 234 | $3,729 | $16 |
| Flecainide Acetate | 39 | $3,696 | $95 |
| Digoxin | 65 | $3,483 | $54 |
| Potassium Chloride | 80 | $3,374 | $42 |
| Bumetanide | 21 | $3,176 | $151 |
| Eplerenone | 20 | $2,974 | $149 |
| Spironolactone | 192 | $2,581 | $13 |
| Metoprolol | 264 | $2,277 | $9 |
| Omega-3 Acid Ethyl Esters | 15 | $2,098 | $140 |
| Telmisartan | 33 | $2,019 | $61 |
| Irbesartan | 65 | $2,010 | $31 |
| Furosemide | 244 | $1,889 | $8 |
| Isosorbide Mononitrate Er | 62 | $1,828 | $29 |
| Sotalol | 41 | $1,822 | $44 |
| Hydrochlorothiazide | 256 | $1,792 | $7 |
| Lisinopril | 219 | $1,721 | $8 |
| Pravastatin | 93 | $1,649 | $18 |
| Diltiazem 24hr Er | 28 | $1,563 | $56 |
| Benazepril | 96 | $1,421 | $15 |
| Cartia Xt | 23 | $1,348 | $59 |
| Hydralazine | 45 | $1,322 | $29 |
| Nitroglycerin Patch | 26 | $1,261 | $48 |
| Olmesartan Medoxomil | 29 | $1,197 | $41 |
| Dilt-Xr | 15 | $1,050 | $70 |
| Nitroglycerin | 51 | $1,048 | $21 |
| Labetalol | 16 | $1,031 | $64 |
| Simvastatin | 67 | $906 | $14 |
| Amiodarone | 51 | $904 | $18 |
| Spironolactone-Hctz | 22 | $830 | $38 |
| Atenolol | 50 | $785 | $16 |
| Propranolol Hcl Er | 15 | $784 | $52 |
| Valsartan-Hydrochlorothiazide | 11 | $642 | $58 |
| Losartan-Hydrochlorothiazide | 20 | $636 | $32 |
| Pantoprazole | 36 | $631 | $18 |
| Diltiazem | 14 | $595 | $43 |
| Verapamil Er | 18 | $515 | $29 |
| Omeprazole | 26 | $441 | $17 |
| Torsemide | 13 | $431 | $33 |
| Doxazosin Mesylate | 20 | $372 | $19 |
| Triamterene-Hydrochlorothiazid | 20 | $357 | $18 |
| Clonidine | 26 | $301 | $12 |
| Lisinopril-Hydrochlorothiazide | 17 | $276 | $16 |
| Propranolol | 14 | $266 | $19 |
| Ramipril | 18 | $256 | $14 |
| Chlorthalidone | 12 | $255 | $21 |
| Amoxicillin | 17 | $56 | $3 |
2020: 66 drugs
| Eliquis | 570 | $532,849 | $935 |
| Xarelto | 112 | $103,747 | $926 |
| Entresto | 104 | $97,942 | $942 |
| Repatha Sureclick | 142 | $70,122 | $494 |
| Praluent | 65 | $39,479 | $607 |
| Pradaxa | 27 | $25,454 | $943 |
| Brilinta | 48 | $25,322 | $528 |
| Atorvastatin | 1,183 | $24,373 | $21 |
| Metoprolol | 634 | $21,612 | $34 |
| Rosuvastatin | 447 | $18,848 | $42 |
| Bystolic | 40 | $18,637 | $466 |
| Ezetimibe | 230 | $13,352 | $58 |
| Diltiazem 24hr Er (Cd) | 191 | $13,009 | $68 |
| Losartan | 719 | $11,226 | $16 |
| Ranolazine Er | 23 | $7,715 | $335 |
| Carvedilol Er | 12 | $5,996 | $500 |
| Warfarin | 229 | $5,935 | $26 |
| Carvedilol | 437 | $5,584 | $13 |
| Digoxin | 97 | $5,443 | $56 |
| Eplerenone | 30 | $5,090 | $170 |
| Clopidogrel | 255 | $4,848 | $19 |
| Valsartan | 64 | $4,767 | $74 |
| Bisoprolol | 70 | $4,163 | $59 |
| Isosorbide Dinitrate | 16 | $3,673 | $230 |
| Amlodipine Besylate | 474 | $3,641 | $8 |
| Flecainide Acetate | 30 | $3,417 | $114 |
| Irbesartan | 60 | $3,254 | $54 |
| Telmisartan | 37 | $3,061 | $83 |
| Spironolactone | 239 | $2,690 | $11 |
| Dofetilide | 13 | $2,603 | $200 |
| Isosorbide Mononitrate Er | 84 | $2,578 | $31 |
| Lisinopril | 252 | $2,514 | $10 |
| Hydrochlorothiazide | 292 | $2,273 | $8 |
| Pravastatin | 107 | $2,178 | $20 |
| Cartia Xt | 47 | $1,968 | $42 |
| Prasugrel | 16 | $1,964 | $123 |
| Potassium Chloride | 67 | $1,954 | $29 |
| Benazepril | 116 | $1,925 | $17 |
| Furosemide | 275 | $1,891 | $7 |
| Metoprolol | 244 | $1,834 | $8 |
| Losartan-Hydrochlorothiazide | 22 | $1,785 | $81 |
| Diltiazem 24hr Er | 25 | $1,755 | $70 |
| Olmesartan Medoxomil | 33 | $1,513 | $46 |
| Amiodarone | 64 | $1,402 | $22 |
| Diltiazem | 13 | $1,385 | $107 |
| Dilt-Xr | 21 | $1,375 | $65 |
| Hydralazine | 52 | $1,246 | $24 |
| Simvastatin | 92 | $1,203 | $13 |
| Nitroglycerin Patch | 22 | $1,163 | $53 |
| Verapamil Er | 24 | $934 | $39 |
| Nitroglycerin | 53 | $926 | $17 |
| Sotalol | 12 | $902 | $75 |
| Atenolol | 56 | $894 | $16 |
| Doxazosin Mesylate | 16 | $722 | $45 |
| Spironolactone-Hctz | 14 | $718 | $51 |
| Pantoprazole | 36 | $678 | $19 |
| Triamterene-Hydrochlorothiazid | 29 | $553 | $19 |
| Ramipril | 15 | $469 | $31 |
| Propranolol | 16 | $419 | $26 |
| Torsemide | 12 | $345 | $29 |
| Omeprazole | 21 | $313 | $15 |
| Lovastatin | 17 | $311 | $18 |
| Lisinopril-Hydrochlorothiazide | 29 | $276 | $10 |
| Klor-Con 10 | 11 | $211 | $19 |
| Clonidine | 16 | $171 | $11 |
| Amoxicillin | 16 | $43 | $3 |
2019: 68 drugs
| Eliquis | 478 | $390,459 | $817 |
| Xarelto | 102 | $92,960 | $911 |
| Entresto | 83 | $75,155 | $905 |
| Alyq | 11 | $56,430 | $5,130 |
| Repatha Sureclick | 79 | $53,851 | $682 |
| Praluent | 62 | $46,727 | $754 |
| Brilinta | 54 | $30,319 | $561 |
| Pradaxa | 35 | $28,081 | $802 |
| Atorvastatin | 1,046 | $23,867 | $23 |
| Metoprolol | 594 | $21,459 | $36 |
| Rosuvastatin | 397 | $19,357 | $49 |
| Bystolic | 36 | $14,936 | $415 |
| Diltiazem 24hr Er (Cd) | 212 | $13,725 | $65 |
| Ezetimibe | 171 | $11,980 | $70 |
| Losartan | 669 | $8,831 | $13 |
| Carvedilol Er | 11 | $6,837 | $622 |
| Ranolazine Er | 21 | $6,283 | $299 |
| Digoxin | 112 | $5,743 | $51 |
| Carvedilol | 408 | $5,549 | $14 |
| Valsartan | 49 | $4,642 | $95 |
| Ezetimibe-Simvastatin | 11 | $4,600 | $418 |
| Warfarin | 226 | $4,444 | $20 |
| Clopidogrel | 221 | $4,394 | $20 |
| Telmisartan | 35 | $4,378 | $125 |
| Potassium Chloride | 86 | $4,023 | $47 |
| Bisoprolol | 72 | $4,012 | $56 |
| Eplerenone | 33 | $3,752 | $114 |
| Amlodipine Besylate | 484 | $3,679 | $8 |
| Isosorbide Dinitrate | 21 | $3,450 | $164 |
| Irbesartan | 62 | $3,196 | $52 |
| Lisinopril | 302 | $3,093 | $10 |
| Cartia Xt | 77 | $3,013 | $39 |
| Isosorbide Mononitrate Er | 91 | $2,905 | $32 |
| Olmesartan Medoxomil | 43 | $2,784 | $65 |
| Pravastatin | 87 | $2,747 | $32 |
| Spironolactone | 241 | $2,694 | $11 |
| Flecainide Acetate | 26 | $2,520 | $97 |
| Amiodarone | 51 | $2,331 | $46 |
| Diltiazem 24hr Er | 27 | $2,143 | $79 |
| Benazepril | 138 | $2,053 | $15 |
| Furosemide | 267 | $1,991 | $7 |
| Enoxaparin | 13 | $1,866 | $144 |
| Prasugrel | 16 | $1,838 | $115 |
| Hydrochlorothiazide | 245 | $1,791 | $7 |
| Omega-3 Acid Ethyl Esters | 15 | $1,721 | $115 |
| Hydralazine | 71 | $1,584 | $22 |
| Metoprolol | 203 | $1,543 | $8 |
| Simvastatin | 103 | $1,363 | $13 |
| Nitroglycerin Patch | 26 | $1,334 | $51 |
| Labetalol | 13 | $1,290 | $99 |
| Dilt-Xr | 23 | $1,230 | $53 |
| Verapamil Er | 28 | $1,140 | $41 |
| Nitroglycerin | 46 | $1,094 | $24 |
| Losartan-Hydrochlorothiazide | 60 | $995 | $17 |
| Telmisartan-Hydrochlorothiazid | 11 | $934 | $85 |
| Bumetanide | 12 | $848 | $71 |
| Atenolol | 53 | $847 | $16 |
| Diltiazem | 14 | $663 | $47 |
| Sotalol | 19 | $614 | $32 |
| Pantoprazole | 28 | $601 | $21 |
| Triamterene-Hydrochlorothiazid | 27 | $541 | $20 |
| Lovastatin | 17 | $427 | $25 |
| Torsemide | 22 | $396 | $18 |
| Lisinopril-Hydrochlorothiazide | 31 | $333 | $11 |
| Omeprazole | 15 | $228 | $15 |
| Ramipril | 15 | $208 | $14 |
| Propranolol | 12 | $189 | $16 |
| Amoxicillin | 28 | $71 | $3 |
2018: 71 drugs
| Eliquis | 407 | $265,219 | $652 |
| Xarelto | 106 | $82,591 | $779 |
| Repatha Sureclick | 53 | $58,989 | $1,113 |
| Praluent | 31 | $45,955 | $1,482 |
| Entresto | 34 | $31,823 | $936 |
| Brilinta | 58 | $28,474 | $491 |
| Pradaxa | 33 | $24,303 | $736 |
| Ranexa | 38 | $23,728 | $624 |
| Ezetimibe | 173 | $23,246 | $134 |
| Atorvastatin | 1,029 | $23,205 | $23 |
| Metoprolol | 580 | $19,900 | $34 |
| Bystolic | 47 | $15,220 | $324 |
| Rosuvastatin | 406 | $14,527 | $36 |
| Diltiazem 24hr Er (Cd) | 165 | $12,250 | $74 |
| Carvedilol Er | 14 | $6,866 | $490 |
| Eplerenone | 51 | $6,822 | $134 |
| Losartan | 592 | $5,898 | $10 |
| Warfarin | 274 | $5,664 | $21 |
| Digoxin | 81 | $5,116 | $63 |
| Valsartan | 105 | $4,710 | $45 |
| Ezetimibe-Simvastatin | 12 | $4,357 | $363 |
| Cartia Xt | 127 | $4,274 | $34 |
| Clopidogrel | 220 | $4,226 | $19 |
| Olmesartan Medoxomil | 39 | $4,094 | $105 |
| Carvedilol | 388 | $4,017 | $10 |
| Crestor | 15 | $3,986 | $266 |
| Pravastatin | 145 | $3,954 | $27 |
| Omega-3 Acid Ethyl Esters | 16 | $3,839 | $240 |
| Isosorbide Mononitrate Er | 112 | $3,829 | $34 |
| Prasugrel | 21 | $3,669 | $175 |
| Bisoprolol | 82 | $3,535 | $43 |
| Diltiazem 24hr Er | 46 | $3,481 | $76 |
| Propafenone Hcl Er | 11 | $3,045 | $277 |
| Amiodarone | 76 | $2,994 | $39 |
| Digox | 37 | $2,961 | $80 |
| Amlodipine Besylate | 428 | $2,765 | $6 |
| Lisinopril | 311 | $2,490 | $8 |
| Isosorbide Dinitrate | 15 | $2,431 | $162 |
| Spironolactone | 232 | $2,392 | $10 |
| Hydrochlorothiazide | 293 | $1,988 | $7 |
| Verapamil Er | 34 | $1,800 | $53 |
| Flecainide Acetate | 28 | $1,777 | $63 |
| Benazepril-Hydrochlorothiazide | 16 | $1,672 | $105 |
| Potassium Chloride | 71 | $1,665 | $23 |
| Irbesartan | 41 | $1,614 | $39 |
| Hydralazine | 94 | $1,531 | $16 |
| Benazepril | 137 | $1,525 | $11 |
| Furosemide | 280 | $1,518 | $5 |
| Labetalol | 23 | $1,439 | $63 |
| Nitroglycerin Patch | 23 | $1,167 | $51 |
| Metoprolol | 163 | $1,139 | $7 |
| Simvastatin | 125 | $1,131 | $9 |
| Nitroglycerin | 49 | $1,126 | $23 |
| Dilt-Xr | 21 | $766 | $36 |
| Losartan-Hydrochlorothiazide | 42 | $704 | $17 |
| Valsartan-Hydrochlorothiazide | 16 | $672 | $42 |
| Sotalol | 32 | $622 | $19 |
| Atenolol | 59 | $610 | $10 |
| Fenofibrate | 12 | $519 | $43 |
| Taztia Xt | 13 | $477 | $37 |
| Triamterene-Hydrochlorothiazid | 39 | $460 | $12 |
| Pantoprazole | 28 | $437 | $16 |
| Spironolactone-Hctz | 11 | $408 | $37 |
| Irbesartan-Hydrochlorothiazide | 21 | $396 | $19 |
| Heparin | 11 | $348 | $32 |
| Lovastatin | 16 | $260 | $16 |
| Omeprazole | 30 | $258 | $9 |
| Torsemide | 21 | $202 | $10 |
| Clonidine | 23 | $192 | $8 |
| Lisinopril-Hydrochlorothiazide | 16 | $113 | $7 |
| Amoxicillin | 22 | $90 | $4 |
2017: 75 drugs
| Eliquis | 335 | $182,061 | $543 |
| Xarelto | 114 | $81,929 | $719 |
| Zetia | 66 | $37,898 | $574 |
| Praluent | 24 | $35,165 | $1,465 |
| Brilinta | 54 | $28,253 | $523 |
| Pradaxa | 40 | $21,246 | $531 |
| Atorvastatin | 855 | $17,659 | $21 |
| Rosuvastatin | 318 | $16,917 | $53 |
| Repatha Sureclick | 13 | $15,440 | $1,188 |
| Ezetimibe | 86 | $15,423 | $179 |
| Metoprolol | 452 | $15,239 | $34 |
| Ranexa | 21 | $13,684 | $652 |
| Entresto | 13 | $13,530 | $1,041 |
| Effient | 14 | $11,121 | $794 |
| Crestor | 23 | $9,583 | $417 |
| Omega-3 Acid Ethyl Esters | 40 | $8,552 | $214 |
| Diltiazem 24hr Er | 167 | $8,040 | $48 |
| Coreg Cr | 16 | $6,841 | $428 |
| Digox | 59 | $5,361 | $91 |
| Warfarin | 256 | $5,279 | $21 |
| Livalo | 12 | $5,268 | $439 |
| Benicar | 12 | $5,113 | $426 |
| Eplerenone | 39 | $5,061 | $130 |
| Valsartan | 114 | $4,876 | $43 |
| Pravastatin | 130 | $4,855 | $37 |
| Digoxin | 81 | $4,466 | $55 |
| Bystolic | 18 | $4,411 | $245 |
| Clopidogrel | 250 | $4,218 | $17 |
| Isosorbide Mononitrate Er | 96 | $3,655 | $38 |
| Losartan | 419 | $3,624 | $9 |
| Carvedilol | 335 | $3,094 | $9 |
| Bisoprolol | 84 | $2,813 | $33 |
| Amiodarone | 62 | $2,571 | $41 |
| Sotalol Af | 14 | $2,570 | $184 |
| Isosorbide Dinitrate | 14 | $2,496 | $178 |
| Benazepril-Hydrochlorothiazide | 19 | $2,417 | $127 |
| Propafenone Hcl Er | 13 | $2,264 | $174 |
| Amlodipine Besylate | 337 | $2,122 | $6 |
| Lisinopril | 310 | $1,960 | $6 |
| Verapamil Er | 38 | $1,919 | $50 |
| Cartia Xt | 72 | $1,859 | $26 |
| Flecainide Acetate | 29 | $1,811 | $62 |
| Olmesartan Medoxomil | 20 | $1,776 | $89 |
| Spironolactone | 186 | $1,552 | $8 |
| Labetalol | 21 | $1,434 | $68 |
| Hydrochlorothiazide | 248 | $1,417 | $6 |
| Nitroglycerin Patch | 30 | $1,411 | $47 |
| Benazepril | 141 | $1,401 | $10 |
| Potassium Chloride | 42 | $1,217 | $29 |
| Irbesartan | 39 | $1,183 | $30 |
| Simvastatin | 134 | $1,182 | $9 |
| Nitroglycerin | 49 | $1,165 | $24 |
| Hydralazine | 70 | $1,155 | $16 |
| Metoprolol | 154 | $1,104 | $7 |
| Fenofibrate | 19 | $931 | $49 |
| Furosemide | 208 | $886 | $4 |
| Dilt-Xr | 24 | $848 | $35 |
| Valsartan-Hydrochlorothiazide | 16 | $789 | $49 |
| Spironolactone-Hctz | 19 | $761 | $40 |
| Atenolol | 89 | $686 | $8 |
| Toprol Xl | 11 | $533 | $48 |
| Sotalol | 23 | $525 | $23 |
| Triamterene-Hydrochlorothiazid | 32 | $462 | $14 |
| Klor-Con 10 | 12 | $370 | $31 |
| Losartan-Hydrochlorothiazide | 27 | $363 | $13 |
| Irbesartan-Hydrochlorothiazide | 11 | $281 | $26 |
| Tamsulosin | 11 | $251 | $23 |
| Ramipril | 16 | $220 | $14 |
| Lovastatin | 21 | $169 | $8 |
| Omeprazole | 15 | $164 | $11 |
| Clonidine | 23 | $155 | $7 |
| Lisinopril-Hydrochlorothiazide | 31 | $147 | $5 |
| Pantoprazole | 20 | $145 | $7 |
| Allopurinol | 11 | $119 | $11 |
| Amoxicillin | 14 | $52 | $4 |
2016: 62 drugs
| Eliquis | 149 | $79,046 | $531 |
| Zetia | 121 | $56,052 | $463 |
| Crestor | 122 | $51,758 | $424 |
| Xarelto | 87 | $50,758 | $583 |
| Brilinta | 46 | $21,223 | $461 |
| Pradaxa | 42 | $19,700 | $469 |
| Vytorin | 23 | $14,181 | $617 |
| Atorvastatin | 577 | $13,131 | $23 |
| Valsartan | 132 | $12,267 | $93 |
| Ranexa | 18 | $11,547 | $642 |
| Rosuvastatin | 100 | $10,909 | $109 |
| Metoprolol | 310 | $10,173 | $33 |
| Omega-3 Acid Ethyl Esters | 36 | $9,615 | $267 |
| Coreg Cr | 23 | $8,357 | $363 |
| Benicar | 22 | $6,447 | $293 |
| Diltiazem 24hr Er | 130 | $6,325 | $49 |
| Digoxin | 109 | $4,704 | $43 |
| Diltiazem 24hr Cd | 55 | $3,908 | $71 |
| Clopidogrel | 183 | $3,873 | $21 |
| Pravastatin | 124 | $3,825 | $31 |
| Eplerenone | 28 | $3,074 | $110 |
| Warfarin | 189 | $3,012 | $16 |
| Carvedilol | 312 | $2,958 | $9 |
| Isosorbide Mononitrate Er | 92 | $2,742 | $30 |
| Digox | 34 | $2,722 | $80 |
| Losartan | 257 | $2,552 | $10 |
| Amiodarone | 50 | $2,172 | $43 |
| Amlodipine Besylate | 301 | $2,054 | $7 |
| Bisoprolol | 56 | $2,052 | $37 |
| Irbesartan | 55 | $1,782 | $32 |
| Lisinopril | 227 | $1,725 | $8 |
| Coumadin | 12 | $1,356 | $113 |
| Benazepril | 126 | $1,293 | $10 |
| Isosorbide Dinitrate | 13 | $1,289 | $99 |
| Spironolactone | 158 | $1,211 | $8 |
| Simvastatin | 139 | $1,209 | $9 |
| Metoprolol | 168 | $1,145 | $7 |
| Potassium Chloride | 51 | $1,095 | $21 |
| Hydrochlorothiazide | 180 | $1,081 | $6 |
| Hydralazine | 70 | $1,068 | $15 |
| Diltiazem Er | 24 | $1,007 | $42 |
| Nitroglycerin Patch | 28 | $998 | $36 |
| Spironolactone-Hctz | 23 | $918 | $40 |
| Toprol Xl | 14 | $864 | $62 |
| Benazepril-Hydrochlorothiazide | 16 | $857 | $54 |
| Enalapril Maleate | 16 | $848 | $53 |
| Nitrostat | 20 | $822 | $41 |
| Furosemide | 185 | $775 | $4 |
| Atenolol | 80 | $611 | $8 |
| Verapamil Er | 23 | $563 | $24 |
| Cartia Xt | 13 | $542 | $42 |
| Sotalol | 14 | $455 | $33 |
| Valsartan-Hydrochlorothiazide | 17 | $440 | $26 |
| Ramipril | 17 | $367 | $22 |
| Lovastatin | 17 | $364 | $21 |
| Triamterene-Hydrochlorothiazid | 23 | $361 | $16 |
| Losartan-Hydrochlorothiazide | 20 | $295 | $15 |
| Klor-Con 10 | 12 | $210 | $17 |
| Clonidine | 13 | $102 | $8 |
| Gabapentin | 12 | $94 | $8 |
| Lisinopril-Hydrochlorothiazide | 14 | $57 | $4 |
| Amoxicillin | 12 | $44 | $4 |
2015: 55 drugs
| Crestor | 113 | $45,938 | $407 |
| Xarelto | 92 | $39,449 | $429 |
| Adcirca | 11 | $28,060 | $2,551 |
| Eliquis | 49 | $25,459 | $520 |
| Zetia | 31 | $16,302 | $526 |
| Pradaxa | 16 | $11,222 | $701 |
| Valsartan | 78 | $10,426 | $134 |
| Brilinta | 28 | $9,856 | $352 |
| Atorvastatin | 422 | $9,726 | $23 |
| Ranexa | 14 | $9,205 | $657 |
| Omega-3 Acid Ethyl Esters | 30 | $8,969 | $299 |
| Vytorin | 16 | $8,626 | $539 |
| Metoprolol | 209 | $7,897 | $38 |
| Effient | 15 | $6,572 | $438 |
| Benicar | 15 | $6,044 | $403 |
| Coreg Cr | 14 | $4,501 | $322 |
| Digoxin | 93 | $4,445 | $48 |
| Warfarin | 152 | $3,373 | $22 |
| Bystolic | 16 | $3,286 | $205 |
| Digox | 33 | $2,796 | $85 |
| Pravastatin | 73 | $2,756 | $38 |
| Eplerenone | 13 | $2,522 | $194 |
| Diltiazem 24hr Er | 43 | $2,001 | $47 |
| Carvedilol | 191 | $1,943 | $10 |
| Diltiazem Er | 36 | $1,872 | $52 |
| Clopidogrel | 129 | $1,764 | $14 |
| Diltiazem 24hr Cd | 38 | $1,716 | $45 |
| Bisoprolol | 53 | $1,448 | $27 |
| Potassium Chloride | 40 | $1,398 | $35 |
| Propafenone | 18 | $1,372 | $76 |
| Simvastatin | 128 | $1,206 | $9 |
| Isosorbide Mononitrate Er | 56 | $1,155 | $21 |
| Losartan | 122 | $1,130 | $9 |
| Amlodipine Besylate | 147 | $1,076 | $7 |
| Benazepril | 85 | $1,072 | $13 |
| Metoprolol | 129 | $1,026 | $8 |
| Hydrochlorothiazide | 111 | $979 | $9 |
| Lisinopril | 128 | $907 | $7 |
| Irbesartan | 34 | $876 | $26 |
| Spironolactone-Hctz | 15 | $827 | $55 |
| Benazepril-Hydrochlorothiazide | 15 | $777 | $52 |
| Furosemide | 147 | $771 | $5 |
| Verapamil Er | 31 | $736 | $24 |
| Taztia Xt | 11 | $683 | $62 |
| Spironolactone | 93 | $682 | $7 |
| Hydralazine | 40 | $511 | $13 |
| Nitrostat | 25 | $497 | $20 |
| Dilt-Xr | 12 | $444 | $37 |
| Atenolol | 51 | $436 | $9 |
| Amiodarone | 20 | $342 | $17 |
| Ramipril | 12 | $323 | $27 |
| Nitroglycerin Patch | 16 | $308 | $19 |
| Sotalol | 13 | $235 | $18 |
| Triamterene-Hydrochlorothiazid | 12 | $223 | $19 |
| Meclizine | 11 | $158 | $14 |
2014: 50 drugs
| Crestor | 132 | $37,426 | $284 |
| Xarelto | 61 | $25,107 | $412 |
| Zetia | 44 | $16,600 | $377 |
| Ranexa | 23 | $12,447 | $541 |
| Eliquis | 22 | $9,473 | $431 |
| Vytorin | 19 | $9,138 | $481 |
| Effient | 30 | $9,058 | $302 |
| Atorvastatin | 353 | $8,963 | $25 |
| Diovan | 37 | $8,714 | $236 |
| Metoprolol | 194 | $8,133 | $42 |
| Pradaxa | 25 | $7,967 | $319 |
| Digoxin | 112 | $5,392 | $48 |
| Valsartan | 26 | $5,043 | $194 |
| Brilinta | 17 | $4,990 | $294 |
| Digox | 70 | $4,253 | $61 |
| Valsartan-Hydrochlorothiazide | 27 | $4,039 | $150 |
| Benicar | 16 | $3,680 | $230 |
| Warfarin | 178 | $3,502 | $20 |
| Livalo | 12 | $2,897 | $241 |
| Diltiazem 24hr Er | 64 | $2,358 | $37 |
| Carvedilol | 183 | $2,355 | $13 |
| Diltiazem 24hr Cd | 20 | $2,162 | $108 |
| Eplerenone | 12 | $2,152 | $179 |
| Pravastatin | 54 | $1,905 | $35 |
| Losartan | 117 | $1,629 | $14 |
| Clopidogrel | 81 | $1,534 | $19 |
| Simvastatin | 115 | $1,447 | $13 |
| Flecainide Acetate | 16 | $1,440 | $90 |
| Bisoprolol | 46 | $1,261 | $27 |
| Diltiazem Er | 27 | $1,184 | $44 |
| Potassium Chloride | 22 | $1,177 | $54 |
| Isosorbide Mononitrate Er | 57 | $1,082 | $19 |
| Propranolol Hcl Er | 15 | $1,048 | $70 |
| Metoprolol | 124 | $1,023 | $8 |
| Amlodipine Besylate | 100 | $1,005 | $10 |
| Lisinopril | 120 | $923 | $8 |
| Labetalol | 16 | $856 | $54 |
| Spironolactone | 87 | $828 | $10 |
| Benazepril | 54 | $813 | $15 |
| Sotalol | 23 | $795 | $35 |
| Hydrochlorothiazide | 79 | $767 | $10 |
| Furosemide | 106 | $619 | $6 |
| Nitrostat | 33 | $512 | $16 |
| Verapamil Er | 12 | $390 | $33 |
| Enalapril Maleate | 15 | $322 | $21 |
| Pantoprazole | 13 | $297 | $23 |
| Atenolol | 23 | $281 | $12 |
| Amiodarone | 13 | $266 | $20 |
| Hydralazine | 18 | $160 | $9 |
| Triamterene-Hydrochlorothiazid | 12 | $149 | $12 |
2013: 49 drugs
| Crestor | 151 | $33,068 | $219 |
| Zetia | 73 | $16,516 | $226 |
| Atorvastatin | 403 | $14,922 | $37 |
| Diovan | 61 | $14,859 | $244 |
| Multaq | 29 | $8,601 | $297 |
| Pradaxa | 21 | $6,917 | $329 |
| Vytorin | 23 | $6,725 | $292 |
| Brilinta | 25 | $6,208 | $248 |
| Metoprolol | 161 | $5,889 | $37 |
| Xarelto | 18 | $5,713 | $317 |
| Lovaza | 11 | $4,492 | $408 |
| Clopidogrel | 92 | $4,084 | $44 |
| Benicar | 27 | $3,902 | $145 |
| Warfarin | 184 | $3,531 | $19 |
| Effient | 13 | $2,991 | $230 |
| Carvedilol | 197 | $2,779 | $14 |
| Valsartan-Hydrochlorothiazide | 15 | $2,415 | $161 |
| Diltiazem 24hr Cd | 20 | $2,403 | $120 |
| Losartan | 134 | $1,999 | $15 |
| Diltiazem Er | 35 | $1,819 | $52 |
| Simvastatin | 139 | $1,731 | $12 |
| Diltiazem 24hr Er | 36 | $1,666 | $46 |
| Amlodipine Besylate | 131 | $1,640 | $13 |
| Sotalol | 33 | $1,621 | $49 |
| Bisoprolol | 47 | $1,398 | $30 |
| Benazepril | 101 | $1,351 | $13 |
| Coumadin | 12 | $1,170 | $98 |
| Pravastatin | 67 | $1,082 | $16 |
| Amiodarone | 48 | $1,078 | $22 |
| Lisinopril | 135 | $1,010 | $7 |
| Isosorbide Mononitrate Er | 55 | $985 | $18 |
| Digox | 90 | $956 | $11 |
| Potassium Chloride | 19 | $918 | $48 |
| Lanoxin | 15 | $637 | $42 |
| Spironolactone | 79 | $636 | $8 |
| Furosemide | 101 | $634 | $6 |
| Digoxin | 44 | $457 | $10 |
| Pantoprazole | 17 | $455 | $27 |
| Metoprolol | 69 | $441 | $6 |
| Hydrochlorothiazide | 58 | $416 | $7 |
| Losartan-Hydrochlorothiazide | 26 | $378 | $15 |
| Atenolol | 32 | $342 | $11 |
| Hydralazine | 15 | $333 | $22 |
| Lisinopril-Hydrochlorothiazide | 21 | $201 | $10 |
| Nitrostat | 13 | $174 | $13 |
| Tamsulosin | 11 | $133 | $12 |
| Triamterene-Hydrochlorothiazid | 12 | $119 | $10 |
| Levothyroxine | 12 | $107 | $9 |
| Metformin | 13 | $78 | $6 |
Money from drug and device companies
$290 in 2025
| 2025 | 5 | 7 | None | $290 |
| 2024 | 7 | 8 | None | $343 |
| 2023 | 4 | 10 | None | $159 |
| 2022 | 8 | 18 | None | $595 |
| 2021 | 5 | 8 | None | $149 |
| 2020 | 9 | 9 | None | $195 |
| 2019 | 8 | 12 | None | $441 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Symplicity G3 | $163 | 3 payments
|
| Philips North America | Mcot | $46 | 1 payment
|
| Stryker | Flowtriever Catheter, S | $36 | 1 payment
|
| Pfizer | Vyndaqel | $23 | 1 payment
|
| Esperion Therapeutics | Nexletol | $22 | 1 payment
|
See all 7 published payments
| Medtronic | Meals · 2025-12-19 | Symplicity G3 | $114 |
| Pfizer | Meals · 2025-05-08 | Vyndaqel | $23 |
| Philips North America | Meals · 2025-04-18 | Mcot | $46 |
| Stryker | Meals · 2025-04-01 | Flowtriever Catheter, S | $36 |
| Esperion Therapeutics | Meals · 2025-02-11 | Nexletol | $22 |
| Medtronic | Meals · 2025-02-06 | Symplicity G3 | $8 |
| Medtronic | Meals · 2025-02-05 | Micra | $41 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $343
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $140 | 1 payment
|
| Medtronic | Ffrangio | $69 | 2 payments
|
| Philips North America | (5044) Mcot | $43 | 1 payment
|
| iRhythm Technologies | Zio Monitor | $25 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $24 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $22 | 1 payment
|
| Esperion Therapeutics | Nexletol | $19 | 1 payment
|
2023: $159
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $47 | 2 payments
|
| Medtronic | Micra | $41 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $41 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $29 | 2 payments
|
2022: $595
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $200 | 3 payments
|
| Amgen | Repatha | $125 | 2 payments
|
| Medtronic | Micra | $97 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $49 | 5 payments
|
| HeartFlow | Ffrct | $34 | 1 payment
|
| Terumo Medical | Tr Band | $32 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $31 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $26 | 2 payments
|
2021: $149
| Philips Electronics North America | (6575) Coronary Undivided | $52 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $32 | 3 payments
|
| Chiesi USA | Kengreal | $25 | 1 payment
|
| Medtronic | Telescope | $21 | 1 payment
|
| HeartFlow | Ffrct | $19 | 1 payment
|
2020: $195
| Abbott Laboratories | Cardiomems Hf System | $46 | 1 payment
|
| Amgen | Repatha | $27 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $24 | 1 payment
|
| Acist Medical Systems | Cvi Systems | $21 | 1 payment
|
| Preventice Services | None | $19 | 1 payment
|
| Abiomed | Impella | $17 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $15 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $14 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $13 | 1 payment
|
2019: $441
| Abbott Laboratories | Mitra Clip System | $215 | 1 payment
|
| Medtronic Vascular | Carelink | $75 | 3 payments
|
| Amgen | Repatha | $41 | 2 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $27 | 1 payment
|
| Pfizer | Eliquis | $26 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $23 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $21 | 2 payments
|
| iRhythm Technologies | Zio Patch | $14 | 1 payment
|
Professional record
- NPI
- 1417955287
- Licence
- CA 413572
- Trained
- Baylor College of Medicine, 1978 · 48 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00C405700
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2005-07-14
- NPI last updated
- 2023-03-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 34 Mark West Springs Rd Fl 3, Santa Rosa, CA, 95403 · 3536 Mendocino Ave, Santa Rosa, CA, 95403